Definitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of “Reduce” by Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average rating of “Reduce” by the seven ratings firms that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $4.28.

Several research analysts have recently issued reports on the company. Robert W. Baird set a $4.00 price objective on Definitive Healthcare in a research note on Friday, August 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Saturday, September 27th. Stifel Nicolaus upped their price target on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st.

Institutional Investors Weigh In On Definitive Healthcare

Several large investors have recently added to or reduced their stakes in DH. ProShare Advisors LLC grew its stake in shares of Definitive Healthcare by 49.1% in the 4th quarter. ProShare Advisors LLC now owns 15,018 shares of the company’s stock valued at $62,000 after buying an additional 4,943 shares during the period. Two Sigma Investments LP grew its stake in Definitive Healthcare by 2,383.1% in the fourth quarter. Two Sigma Investments LP now owns 285,555 shares of the company’s stock valued at $1,174,000 after acquiring an additional 274,055 shares during the period. Two Sigma Advisers LP grew its stake in Definitive Healthcare by 1,301.5% in the fourth quarter. Two Sigma Advisers LP now owns 189,200 shares of the company’s stock valued at $778,000 after acquiring an additional 175,700 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Definitive Healthcare by 6.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 81,358 shares of the company’s stock valued at $334,000 after purchasing an additional 4,748 shares during the period. Finally, Baker Tilly Wealth Management LLC grew its position in Definitive Healthcare by 19.2% in the 1st quarter. Baker Tilly Wealth Management LLC now owns 60,080 shares of the company’s stock valued at $174,000 after purchasing an additional 9,680 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 2.7%

Shares of DH opened at $3.42 on Tuesday. Definitive Healthcare has a one year low of $2.15 and a one year high of $5.68. The company has a market cap of $489.54 million, a P/E ratio of -1.29 and a beta of 1.65. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a 50 day simple moving average of $3.94 and a two-hundred day simple moving average of $3.52.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.